CHORD1 CHOlesterol Lowering and Residual Risk in Diabetes Type 1
Brief description of study
This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather information and record any developments of the outcomes in question. This study will recruit 125 participants with Type 1 Diabetes (T1D) to:
Clinical Study Identifier: s22-01095
ClinicalTrials.gov Identifier: NCT05641753
Principal Investigator:
Ira J Goldberg.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.